Voriconazole for stubborn ringworm infections
Part of Infections, Skin clinical trials.
This trial tests a stronger antifungal pill, voriconazole, for people whose ringworm (a fungal skin infection) hasn't cleared up after other treatments. It focuses on infections on the groin or trunk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a stubborn ringworm infection on your groin or trunk that didn't improve after 4 weeks of standard antifungal pills.
- The infected area is between about 2 inches and 31 inches across.
- You are not allergic to azole medicines (like fluconazole).
- You do not have a weak immune system (e.g., from cancer, HIV, or an organ transplant).
- You do not have diabetes, liver disease, or kidney disease, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two oral medications, fluconazole and itraconazole, to see which works better for treating ringworm that hasn't cleared up with topical creams. If you've had ringworm for at least 6 months despite using antifungal creams, this study may help find a more effective treatment.
This trial tests if adding a second medication, isotretinoin, to the standard itraconazole treatment works faster or better for adults with ringworm on their body. It aims to find a safer and more effective way to treat this common fungal skin infection.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
This trial tests if ultraviolet B (UVB) phototherapy can treat ringworm infections that have not improved with standard antifungal pills or have come back multiple times. It may be an option if you still have symptoms after taking terbinafine or itraconazole for at least 4 weeks.
This trial compares a skin cream (clotrimazole) to a pill (itraconazole) to see which works better for treating pityriasis versicolor, a common fungal skin infection. If you have this condition and haven't used antifungal treatments recently, you may be able to join.
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
Hear when a new Dermatophyte Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.